GPR161

gene product
RE2
The protein encoded by this gene is an orphan G protein-coupled receptor whose ligand is unknown. This gene is overexpressed in triple-negative breast cancer, and disruption of this gene slows the proliferation of basal breast cancer cells. Therefore, this gene is a potential drug target for triple-negative breast cancer. [provided by RefSeq, Mar 2017]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
246 antibodies from 27 providers.

Antibody properties

General

Applications

or Cancel
Antibody
antibodies-online
92 antibodies
Proteintech Group
1 antibody
Affinity Biosciences
2 antibodies
NovoPro Bioscience Inc.
6 antibodies
LifeSpan BioSciences, Inc.
57 antibodies
Novus Biologicals
9 antibodies
Aviva Systems Biology
4 antibodies
OriGene
7 antibodies
Abnova Corporation
4 antibodies
Acris Antibodies GmbH
2 antibodies
Invitrogen Antibodies
7 antibodies
Biorbyt
12 antibodies
ProSci
4 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Boster Biological Technology
1 antibody
Atlas Antibodies
2 antibodies
GeneTex
2 antibodies
Creative Biolabs
4 antibodies
Creative Diagnostics
3 antibodies
MyBioSource
3 antibodies
Abgent
5 antibodies
Sigma-Aldrich
5 antibodies
St John's Laboratory
1 antibody
United States Biological
5 antibodies
RayBiotech, Inc.
3 antibodies
GenWay
1 antibody
Abbexa
3 antibodies